NCT04204252Phase 3Terminated

Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"

Study sponsor: Kamada, Ltd. · KMDA

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2026-02-19Actual
Enrollment · participants98Actual
Source updated2026-08-12Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 5 fields changed

Participant count type changed

− Before

Estimated

+ After

Actual

Enrollment · participant count changed

− Before

220 participants (planned)

+ After

98 participants (actual)

Completion date type changed

− Before

Estimated

+ After

Actual

Primary completion date changed

− Before

Dec 2028

+ After

19 Feb 2026

Recruitment status changed

− Before

Recruiting

+ After

Terminated

Check registry source